Seres Therapeutics Receives $3.6 Million CARB-X Grant to Develop Liquid Form of SER-155 for Infection Prevention Read more
FDA Moves to Streamline Biosimilar Development, Cut Costs and Speed Access to Affordable Biologic Alternatives Read more
AI in Drug Discovery 2026: Novo Nordisk’s Peter Clark to Chair Landmark Event Driving AI Integration in Pharma Read more
Kazia to Seek FDA Feedback on Conditional Approval Pathway for Paxalisib in Newly Diagnosed Glioblastoma Read more
Guardant Health and Zephyr AI Partner to Advance Cancer Drug Development Through AI-Driven Insights Read more
FDA Expands Approval of Merck’s WINREVAIR for Pulmonary Arterial Hypertension Following Strong Phase 3 Results Read more
Hemab Therapeutics Secures $157 Million Series C to Advance Breakthrough Treatments for Rare Bleeding Disorders Read more